Janssen, Bayer Lose Preemption Bids As Xarelto Trial Nears
Days before a first bellwether trial begins in multidistrict litigation over the alleged dangers of blood thinner Xarelto, a Louisiana federal judge on Wednesday refused to drop some claims against Bayer...To view the full article, register now.
Already a subscriber? Click here to view full article